Department of Pediatrics, Harran University, Medical Faculty, Faculty of Medicine, Harran University, Osmanbey Campus, Haliliye, Sanlıurfa, Turkey.
J Glob Antimicrob Resist. 2020 Mar;20:68-73. doi: 10.1016/j.jgar.2019.07.019. Epub 2019 Jul 21.
In this study, we aimed at identifying community and hospital-induced uropathogens isolated in urinary tract infection (UTI) determining the regional antibiotic resistance and the antibiotic preferences in empirical treatment in Sanliurfa/Turkey.
The urinary culture results of the 842 paediatric patients, who were aged between 0 and 18 years, admitted to Department of Pediatrics, Harran University Medi-cal Faculty Hospital, Sanliurfa, Turkey with UTI complaints, diagnosed with UTI and in whose urine cultures production was detected, were retrospectively evaluated. Age, gender, clinical findings and culture results of the patients were examined in terms of reproducing pathogens, the frequency of their being community and hospital induced, Extended Spectrum Beta Lactamase production of reproduced pathogens, sensitivity and resistance to antibiotics.
A total of 842 patients, 472 (56.1%) girl were included in the study. According to the results of urine culture, Escherichia coli was detected in (58.9%) of the patients, Klebsiella (17.9%) and Proteus (15.8%). While high resistance to ampicillin (87.3%), cefuroxime (71.6%) and trimethoprim-sulfamethoxazole (60.8%) was found for all microorganisms, the lowest resistance to nitrofurantoin (21.4%), piperacillin/tazobactam (19.1), imipenem (8.6%), meropenem (8.8%), amikacin (6.2%) and cefoperazone/sulbactam (CSL) (4.7%) were determined in descending order. Resistance rates were higher in inpatients with UTI than in outpatients.
We think that the most appropriate antibiotic to be chosen for the outpatients for empirical treatment in all age groups in our region, is as oral nitrofurantoin and parenteral amikacin. Also the appropriate parenteral antibiotics that should be selected for the empirical treatment of inpatients UTI in all age groups are the CSL, amikacin and carbapenems.
本研究旨在鉴定在土耳其桑利乌尔法地区尿路感染(UTI)中分离出的社区和医院相关尿病原体,确定局部抗生素耐药性和经验性治疗中的抗生素偏好。
回顾性分析了土耳其桑利乌尔法哈兰大学医学院附属医院儿科 842 例年龄在 0 至 18 岁之间因 UTI 就诊、诊断为 UTI 且尿液培养有产生产物的患儿的尿培养结果。检查患者的年龄、性别、临床发现和培养结果,以确定病原体、社区和医院来源的频率、产生的扩展谱β内酰胺酶、抗生素的敏感性和耐药性。
共纳入 842 例患者,其中 472 例(56.1%)为女孩。根据尿培养结果,842 例患者中检出大肠埃希菌(58.9%)、肺炎克雷伯菌(17.9%)和变形杆菌(15.8%)。所有微生物对氨苄西林(87.3%)、头孢呋辛(71.6%)和复方磺胺甲噁唑(60.8%)的耐药率较高,而对呋喃妥因(21.4%)、哌拉西林/他唑巴坦(19.1%)、亚胺培南(8.6%)、美罗培南(8.8%)、阿米卡星(6.2%)和头孢哌酮/舒巴坦(CSL)(4.7%)的耐药率较低。住院患者的耐药率高于门诊患者。
我们认为,在我们地区,所有年龄段的门诊患者经验性治疗的最合适的抗生素是口服呋喃妥因和静脉用阿米卡星。此外,所有年龄段住院患者 UTI 经验性治疗的合适的静脉用抗生素是 CSL、阿米卡星和碳青霉烯类抗生素。